Tennessee Tasigna Lawyer
Tasigna is the brand name for the drug nilotinib, which is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML). This is a serious form of blood cancer caused by an abnormal chromosome that leads to the production of excess white blood cells. According to Novartis Pharmaceuticals Corporation, which distributes Tasigna, the drug functions as an inhibitor that prevents the cancerous cells from reproducing.
During the past decade, Novartis aggressively marketed Tasigna as the successor to one of its earlier drugs, Gleevec, which is no longer under patent protection. In 2010, the FDA issued a cease-and-desist letter to Novartis over its misbranding of Tasigna as a “next generation” treatment that was superior to previous drugs–a claim not supported by science. Additionally, the U.S. Department of Justice obtained a $390 million civil judgment from Novartis in 2013 over allegations the company used illegal kickbacks to convince doctors to prescribe Tasigna.
Even more alarmingly, many patients to this day report serious side effects and complications arising from the use of Tasigna. If you are among these patients, you may be entitled to compensation for your injuries and related losses. The experienced Tennessee Tasigna lawyers at Fox & Farley can review your case and help you decide whether or not to pursue legal action against Novartis.
Novartis’ Failure to Warn U.S. Patients About Potentially Deadly Side Effects
The main Tasigna side effect of concern is atherosclerosis, more commonly known as a “hardening of the arteries.” This occurs when plaque builds up inside a patient’s arteries, which can restrict the flow of blood to the heart and other parts of the bodies. Atherosclerosis-related complications include coronary heart disease, carotid (neck and brain) artery disease, peripheral artery disease (arms and legs), and chronic kidney disease. In many cases these complications lead to amputations, heart attacks, strokes, and even death.
In 2013, Canadian health authorities advised doctors and patients in that country that there was an increased risk of developing atherosclerosis and its related conditions while taking Tasigna. Novartis failed to issue similar warnings to doctors and patients in the United States. Under Tennessee product liability law, a drug manufacturer can be held responsible for a “failure to warn” consumers, especially when there is evidence that the company had prior knowledge of a potentially deadly side effect.
Our Tennessee Tasigna Lawyers Are Ready to Assist You
If you have suffered personal injury after using Tasigna, or if you believe that the drug contributed to the death of a family member, you should contact Fox & Farley, Attorneys at Law, right away at (866) 862-4855. A member of our legal team will schedule a free consultation so we can sit down and discuss the specifics of your case, as well as outline your options for pursuing legal action against Novartis and other responsible parties.
Fox & Farley serves clients in Tennessee cities such as Knoxville, Clinton, Oak Ridge, Kingston, La Follette, Maryville, Sevierville, Pigeon Forge, Gatlinburg and others throughout Knox County, Anderson County, Roane County, Macon County, Blount County, Campbell County, Claiborne County, Morgan County, Scott County, Sevier County, and Union County.